GP9 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P14770 |
---|---|
Clone Names | 100430115 |
Gene ID | 2815 |
---|---|
Other Names | Platelet glycoprotein IX, GP-IX, GPIX, Glycoprotein 9, CD42a, GP9 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | GP9 |
---|---|
Function | The GPIb-V-IX complex functions as the vWF receptor and mediates vWF-dependent platelet adhesion to blood vessels. The adhesion of platelets to injured vascular surfaces in the arterial circulation is a critical initiating event in hemostasis. GP-IX may provide for membrane insertion and orientation of GP-Ib. |
Cellular Location | Membrane; Single-pass type I membrane protein. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a small membrane glycoprotein found onthe surface of human platelets. It forms a 1-to-1 noncovalentcomplex with glycoprotein Ib, a platelet surface membraneglycoprotein complex that functions as a receptor for vonWillebrand factor. The complete receptor complex includesnoncovalent association of the alpha and beta subunits with theprotein encoded by this gene and platelet glycoprotein V. Defectsin this gene are a cause of Bernard-Soulier syndrome, also known asgiant platelet disease. These patients have unusually largeplatelets and have a clinical bleeding tendency. [provided byRefSeq].
References
Munday, A.D., et al. J. Thromb. Haemost. 8(1):163-172(2010)Mo, X., et al. J. Thromb. Haemost. 7(9):1533-1540(2009)Mangin, P.H., et al. J. Thromb. Haemost. 7(9):1550-1555(2009)Strassel, C., et al. Haematologica 94(6):800-810(2009)Zieger, B., et al. Hamostaseologie 29(2):161-167(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.